MedTrace Logo

Effectiveness of Myofascial Release in Patients With Chronic Post Sternotomy Pain Syndrome

NCT06630208 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-10-08

No results posted yet for this study

Summary

The main aim of this study is to investigate the effectiveness of Myofascial release in patients with chronic sternotomy pain.

Conditions

  • Chronic Postsurgical Pain

Interventions

OTHER

Myofascial release

The experimental group will undergo a 5-day consecutive myofascial release treatment, administered as Osteopathic Manipulative Treatment (OMT), with each session lasting a maximum of 15 minutes. The treatment will consist of three phases targeting the entire mediastinum: Thoracic Inlet (Indirect) Myofascial Release, Rib Raising with continued stretch of the paraspinal muscles to the L2 vertebral level, and Soft Tissue Cervical Paraspinal Muscle Stretch with Suboccipital Muscle Release. Participants will be positioned in a supine posture to enhance diaphragmatic excursion, with each session following a fixed, prearranged sequence of these techniques.

OTHER

Breathing exercises

Following the 3 phases of myofascial release, breathing exercises will be done for patients.

DRUG

Pharmacological treatment

Patients will take pharmacological treatment prescribed by the cardiologist.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmad Mahdi Ahmad, PhD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-15
Primary Completion
2025-02-15
Completion
2025-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06630208 on ClinicalTrials.gov